in silico ADME prediction
Product News May 13, 2009
ACD/ADME Suite is a collection of software modules that provide predictions of properties relating to the pharmacokinetic profiling of compounds.
Predict P-gp specificity, oral bioavailability, passive absorption, blood barrier permeation, distribution, P450 inhibitors, CYP3A4 specificity, maximum recommended daily dose, solvation parameters, and more. Predictions are based on a combination of expert knowledge, scientific intuition, and QSAR modelling. An estimation of prediction reliability is provided, and training allows accuracy to be extended to proprietary chemical space.
Reduce the need for expensive, labor-intensive experimental testing, and focus research efforts on molecules that meet property requirements. ACD/ADME Suite is a better way to turn data into decisions.